Summer S Han1, S Ayca Erdogan2, Iakovos Toumazis3, Ann Leung4, Sylvia K Plevritis5. 1. Quantitative Sciences Unit, Stanford Center for Biomedical Research (BMIR), Neurosurgery and Medicine, Stanford University School of Medicine, Stanford, CA, USA. 2. Department of Industrial and Systems Engineering, San Jose State University, San Jose, CA, USA. 3. Department of Radiology and Biomedical Data Science, Stanford University School of Medicine, 1201 Welch Rd, Stanford, CA, 94305, USA. 4. Department of Radiology, Stanford University School of Medicine, Stanford, CA, 94305, USA. 5. Department of Radiology and Biomedical Data Science, Stanford University School of Medicine, 1201 Welch Rd, Stanford, CA, 94305, USA. sylvia.plevritis@stanford.edu.
Abstract
BACKGROUND: The US preventive services task force (USPSTF) recently recommended that individuals aged 55-80 with heavy smoking history be annually screened by low-dose computed tomography (LDCT), thereby extending the stopping age from 74 to 80 compared to the national lung screening trial (NLST) entry criterion. This decision was made partly with model-based analyses from cancer intervention and surveillance modeling network (CISNET), which assumed perfect compliance to screening. METHODS: As part of CISNET, we developed a microsimulation model for lung cancer (LC) screening and calibrated and validated it using data from NLST and the prostate, lung, colorectal, and ovarian cancer screening trial (PLCO), respectively. We evaluated population-level outcomes of the lifetime screening program recommended by the USPSTF by varying screening compliance levels. RESULTS: Validation using PLCO shows that our model reproduces observed PLCO outcomes, predicting 884 LC cases [Expected(E)/Observed(O) = 0.99; CI 0.92-1.06] and 563 LC deaths (E/O = 0.94 CI 0.87-1.03) in the screening arm that has an average compliance rate of 87.9% over four annual screening rounds. We predict that perfect compliance to the USPSTF recommendation saves 501 LC deaths per 100,000 persons in the 1950 U.S. birth cohort; however, assuming that compliance behaviors extrapolated and varied from PLCO reduces the number of LC deaths avoided to 258, 230, and 175 as the average compliance rate over 26 annual screening rounds changes from 100 to 46, 39, and 29%, respectively. CONCLUSION: The implementation of the USPSTF recommendation is expected to contribute to a reduction in LC deaths, but the magnitude of the reduction will likely be heavily influenced by screening compliance.
BACKGROUND: The US preventive services task force (USPSTF) recently recommended that individuals aged 55-80 with heavy smoking history be annually screened by low-dose computed tomography (LDCT), thereby extending the stopping age from 74 to 80 compared to the national lung screening trial (NLST) entry criterion. This decision was made partly with model-based analyses from cancer intervention and surveillance modeling network (CISNET), which assumed perfect compliance to screening. METHODS: As part of CISNET, we developed a microsimulation model for lung cancer (LC) screening and calibrated and validated it using data from NLST and the prostate, lung, colorectal, and ovarian cancer screening trial (PLCO), respectively. We evaluated population-level outcomes of the lifetime screening program recommended by the USPSTF by varying screening compliance levels. RESULTS: Validation using PLCO shows that our model reproduces observed PLCO outcomes, predicting 884 LC cases [Expected(E)/Observed(O) = 0.99; CI 0.92-1.06] and 563 LC deaths (E/O = 0.94 CI 0.87-1.03) in the screening arm that has an average compliance rate of 87.9% over four annual screening rounds. We predict that perfect compliance to the USPSTF recommendation saves 501 LC deaths per 100,000 persons in the 1950 U.S. birth cohort; however, assuming that compliance behaviors extrapolated and varied from PLCO reduces the number of LC deaths avoided to 258, 230, and 175 as the average compliance rate over 26 annual screening rounds changes from 100 to 46, 39, and 29%, respectively. CONCLUSION: The implementation of the USPSTF recommendation is expected to contribute to a reduction in LC deaths, but the magnitude of the reduction will likely be heavily influenced by screening compliance.
Entities:
Keywords:
CISNET; CT screening; Lung cancer; Microsimulation; NLST; Public health policy; USPSTF
Authors: Heber MacMahon; John H M Austin; Gordon Gamsu; Christian J Herold; James R Jett; David P Naidich; Edward F Patz; Stephen J Swensen Journal: Radiology Date: 2005-11 Impact factor: 11.105
Authors: Rebecca M Lindell; Thomas E Hartman; Stephen J Swensen; James R Jett; David E Midthun; Henry D Tazelaar; Jayawant N Mandrekar Journal: Radiology Date: 2007-02 Impact factor: 11.105
Authors: Pamela M McMahon; Chung Yin Kong; Colleen Bouzan; Milton C Weinstein; Lauren E Cipriano; Angela C Tramontano; Bruce E Johnson; Jane C Weeks; G Scott Gazelle Journal: J Thorac Oncol Date: 2011-11 Impact factor: 15.609
Authors: Rafael Meza; Kevin ten Haaf; Chung Yin Kong; Ayca Erdogan; William C Black; Martin C Tammemagi; Sung Eun Choi; Jihyoun Jeon; Summer S Han; Vidit Munshi; Joost van Rosmalen; Paul Pinsky; Pamela M McMahon; Harry J de Koning; Eric J Feuer; William D Hazelton; Sylvia K Plevritis Journal: Cancer Date: 2014-02-27 Impact factor: 6.860
Authors: Summer S Han; Eric Chow; Kevin Ten Haaf; Iakovos Toumazis; Pianpian Cao; Mehrad Bastani; Martin Tammemagi; Jihyoun Jeon; Eric J Feuer; Rafael Meza; Sylvia K Plevritis Journal: J Natl Cancer Inst Date: 2020-11-01 Impact factor: 13.506
Authors: Summer S Han; Kevin Ten Haaf; William D Hazelton; Jihyoun Jeon; Rafael Meza; Chung Yin Kong; Eric J Feuer; Harry J de Koning; Sylvia K Plevritis Journal: Int J Cancer Date: 2017-12-28 Impact factor: 7.396
Authors: Erin A Hirsch; Anna E Barón; Betsy Risendal; Jamie L Studts; Melissa L New; Stephen P Malkoski Journal: J Am Coll Radiol Date: 2021-03-30 Impact factor: 6.240
Authors: Rami A El Shafie; Dorothea Weber; Nina Bougatf; Tanja Sprave; Dieter Oetzel; Peter E Huber; Jürgen Debus; Nils H Nicolay Journal: JMIR Mhealth Uhealth Date: 2018-08-30 Impact factor: 4.773
Authors: Peter J Mazzone; Gerard A Silvestri; Lesley H Souter; Tanner J Caverly; Jeffrey P Kanne; Hormuzd A Katki; Renda Soylemez Wiener; Frank C Detterbeck Journal: Chest Date: 2021-07-13 Impact factor: 9.410
Authors: Peter J Mazzone; Gerard A Silvestri; Lesley H Souter; Tanner J Caverly; Jeffrey P Kanne; Hormuzd A Katki; Renda Soylemez Wiener; Frank C Detterbeck Journal: Chest Date: 2021-07-13 Impact factor: 9.410
Authors: Eduardo R Núñez; Tanner J Caverly; Sanqian Zhang; Mark E Glickman; Shirley X Qian; Jacqueline H Boudreau; Christopher G Slatore; Donald R Miller; Renda Soylemez Wiener Journal: JAMA Netw Open Date: 2021-07-01